new post
StocksRunner logo
mail
search
 
menu
 
ADC Therapeutics SA
$4.88
+1.67%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  

 

ADCT Stock Analysis & IQ Rating | ADC Therapeutics SA

 
 

ADCT

 

ADC Therapeutics SA

$4.88

 
+$0.08 | +1.67%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  

 
 
52W High
$4.98
 
 
MKT CAP
$604.52M
 
52W Low
$1.05
 
 
VOL
$1.27M
 
P/E Ratio
N/A
 
 
AVG VOL
$870.59K
 
RSI
69.96
 
 
TREND
Sideways
 
 
 

ADCT Stock IQ

 
lock  Login to see ADC Therapeutics SA (ADCT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

ADCT Target Price

 
 
Not Enough Information
 
 
 

Strengths

 
 

ADCT Rewards

 Upgraded on attractively valued

 
 

ADCT Price Performance

 
 

$3.91   (+24.81%)

$4.23   (+15.37%)

$4.26   (+14.55%)

$1.41   (+246.10%)

 
 
1year
6month
3month
1month

ADCT Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

ADCT Earnings Sentiment Above analyst estimates

Rating

×

Rating

ADCT Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

ADCT Momentum Analysis Has been gaining momentum

Activity

×

Activity

Future

×

Future

ADCT Analysts Opinion

ADCT Analysts opinion is negative and it remained unchanged from the past 3 months

ADCT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

100%
Consensus Rating
100%
Buy
Opinion
100%
Trend
Score
100%
Potential
Score
ADCT Street Sentiment

ADCT Street Sentiment is extremely bullish and have negative views on the near-term outlook

ADCT Risk Level

ADCT has Medium risk level

Risk Indicators

Beta greater than 1.0
Price under $5
ADCT Risk Level
Medium
LOW
HIGH

ADCT Performance Sentiment

Sentiments overview associated with events and the stock performance

100%
Positive
3 out of 3
events present
0%
Negative
0 out of 3
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
100%
Consensus Rating
STRONG BUY
2
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm

Dec 29, 2025

 

Upgrade

 

Buy

 

Zacks

 

Nov 18, 2025

 

Upgrade

 

Buy

 

Zacks

 

Oct 16, 2025

 

Reiterate

 

Buy

 

HC Wainwright & Co.

 
 
 
ADCT Latest Analysis +

 
 
FAQ About ADCT Stock Insights
 

What is ADCT current stock price?

What are ADCT stock strengths?

What is ADCT Risk Level?

What is ADCT market cap and volume?

What is ADCT current Stock IQ?

Should I buy ADCT stock right now?

Is ADCT a Strong Buy right now?

What does a 'Strong Buy' rating mean for ADCT?

What does a 'Strong Sell' rating mean for ADCT?

What factors influence ADCT's Stock IQ?

 
 
StocksRunner

Explore our ADCT Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored ADCT Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our ADCT Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

ADCT

 

ADC Therapeutics SA

 
Set Alerts
 
 

Current Price

 

$4.88

 
+$0.08 | +1.67%
 
 
52W High
$4.98
 
 
MKT CAP
$604.52M
 
52W Low
$1.05
 
 
VOL
$1.27M
 
P/E Ratio
N/A
 
 
AVG VOL
$870.59K
 
RSI
69.96
 
 
TREND
Sideways
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  

 
 
 
 
user
 
 
 
 

ADCT Price Performance

 
 

$3.91   (+24.81%)

$4.23   (+15.37%)

$4.26   (+14.55%)

$1.41   (+246.10%)

 
 
1year
6month
3month
1month
 

ADCT Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

ADCT Earnings Sentiment Above analyst estimates

Rating

×

Rating

ADCT Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

ADCT Momentum Sentiment Has been gaining momentum

Activity

×

Activity

Future

×

Future

ADCT Analysts Opinion

ADCT Analysts opinion is negative and it remained unchanged from the past 3 months

ADCT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

100%
Consensus Rating
100%
Buy
Opinion
100%
Trend
Score
100%
Potential
Score
ADCT Street Sentiment

ADCT Street Sentiment is extremely bullish and have negative views on the near-term outlook

ADCT Risk Level

ADCT has Medium risk level

Risk Indicators

Beta greater than 1.0
Price under $5
ADCT Risk Level
Medium
LOW
HIGH
ADCT Performance Sentiment
Sentiments overview associated with events and the stock performance.
100%
Positive
3 out of 3
events present
0%
Negative
0 out of 3
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Latest Analyst Actions

Overall Wall Street Rating

100%
Consensus Rating
STRONG BUY
2
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm
Dec 29, 2025
Upgrade
Buy
Zacks
Nov 18, 2025
Upgrade
Buy
Zacks
Oct 16, 2025
Reiterate
Buy
HC Wainwright & Co.
 
 
 
 

ADCT Stock IQ

 
 
 
lock  Login to unlock ADC Therapeutics SA (ADCT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

ADCT Rewards

 Upgraded on attractively valued

 
 
 

ADCT Latest Analysis

 
 
 

ADC Therapeutics Narrows Losses Supported By Higher Product Revenue And Ongoing Restructuring . (RTTNews) - ADC Therapeutics SA (ADCT) has reported its fourth quarter and full-year 2025 financial results showing improved net loss figures compared with the prior year as the company continues to streamline operations and advance its ZYNLONTA clinical programs.

 

Tue Mar 10, 2026

$4.80 | +13.88%
 
Activity

ADC Therapeutics Non-GAAP EPS of -$0.05 revenue of $23.06M beats by $0.77M.

 

Tue Mar 10, 2026

$4.80 | +13.88%
 
Earnings

What to Expect from ADC Therapeuticss Earnings. ADC Therapeutics (NYSE:ADCT) is gearing up to announce its quarterly earnings on Tuesday 2026-03-10. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that ADC Therapeutics will report an earnings per share (EPS) of $-0.29.Anticipation surrounds ADC Therapeutics'.s announcement with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.Ne

 

Mon Mar 9, 2026

$4.23 | +2.92%
 
Momentum

 
 
 
 
 
StocksRunner

Discover ADCT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ADCT. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our ADCT Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ADCT Stock trends

ADCT Stock performance

ADCT Stock analysis

ADCT investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

ADCT Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 

 
Cancel
 
×
 
0/666
joker
 
Post
 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing ADCT

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing ADCT

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.